Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Omicron Stalls TUI Recovery

Published 08/12/2021, 13:24
Updated 08/12/2021, 13:24
© Reuters

By Catherine Reynolds 

Investing.com --  TUI Group (LON:TUIT) shares were down 4.7% by mid-session in Europe as the emergence of the new Omicron variant stalled its vaccine-driven recovery from the pandemic as winter holiday bookings took a hit from the development. TUI posted end of year results showing that Winter 2021/22 bookings are 62% of winter 18/19 levels. Before the recent news coverage, they had been returning to normal levels, the travel group said.

“The increased media coverage of rising incident rates and the emergence of new Omicron variant has weakened this positive momentum, particularly for Winter," the group said in a release to the stock exchange.

The success of vaccination programmes and rebound of leisure travel had driven a recovery for TUI with fourth quarter revenues up €2.1 billion compared to Q4 2020. The fourth quarter saw the holiday group deliver its first positive quarterly EBITDA since the pandemic started, at 160 million euros.

If sentiment continues to be hit by the new Covid variant, winter season capacity is likely to be modified towards the lower end of assumptions of between 60% to 80%, TUI said. However, the group also forecast a bounce back in the summer 2022 season, where bookings have increased. The U.K., which books summer holidays earlier, is already 52% sold for May with total markets and airlines bookings for the key August holiday period up 17%. 

TUI said it expected that Summer 22 volumes would recover close to normalized Summer 19 levels, supported by the stronger starting position and a travel environment underpinned by the continued success of vaccination campaigns. The holiday giant forecast that world arrivals would show a strong increase in 2022 and return to normal in 2023 and 2024.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.